The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
2
- 1
Sutcliffe, John
Born in June 1974Individual (5 offsprings)Officer
2023-07-01 ~ nowOF - Director → CIF 0 - 2PRINCIPLE HEALTHCARE INTERNATIONAL LIMITED - nowBIOCALTH INTERNATIONAL (UK) LIMITED - 2009-07-23
Airedale Busienss Centre, Millenium Road, Skipton, EnglandActive Corporate (1 parent, 1 offspring)Equity (Company account)1,287,351 GBP2024-12-31Person with significant control 2016-04-06 ~ nowPE - Ownership of shares – 75% or more → CIF 0
Ceased
14
- 1
Carlin, Bruce
Company Director born in July 1954IndividualOfficer 2002-05-21 ~ 2010-02-03OF - Director → CIF 0 - 2
Doyle, Richard
Individual (26 offsprings)Officer 2016-01-21 ~ 2020-11-02OF - Secretary → CIF 0 - 3
Davies, Andrew Michael
Director born in April 1982Individual (3 offsprings)Officer 2011-10-01 ~ 2023-12-31OF - Director → CIF 0 - 4
Weber, Stephan Martin Franz Maria
Managing Director born in March 1964Individual (2 offsprings)Officer 2022-01-01 ~ 2023-06-30OF - Director → CIF 0 - 5
Campbell, Clare
Company Director born in June 1975Individual (3 offsprings)Officer 2002-04-30 ~ 2019-03-10OF - Director → CIF 0Campbell, Clare
Individual (3 offsprings)Officer 2001-09-07 ~ 2002-04-30OF - Secretary → CIF 0 - 6
Avery, Andrew Mark
Company Director born in March 1968IndividualOfficer 2001-09-07 ~ 2005-10-17OF - Director → CIF 0 - 7
Barker, Stuart
Director born in December 1958Individual (1 offspring)Officer 2010-12-01 ~ 2013-09-15OF - Director → CIF 0 - 8
Birchall, Anita
Finance ManagerIndividualOfficer 2004-07-02 ~ 2016-01-21OF - Secretary → CIF 0 - 9
Dove, Paul Alec
Business Consultant born in October 1954Individual (2 offsprings)Officer 2006-09-26 ~ 2009-07-22OF - Director → CIF 0 - 10
Ray, Geraldine Ann
Financial Controller born in October 1965IndividualOfficer 2002-04-30 ~ 2004-07-02OF - Director → CIF 0Ray, Geraldine Ann
IndividualOfficer 2002-04-30 ~ 2004-07-02OF - Secretary → CIF 0 - 11
Lazenby, Fiona Louise
Director born in July 1975IndividualOfficer 2010-12-01 ~ 2016-05-26OF - Director → CIF 0 - 12
Davies, Michael John
Director born in January 1951Individual (3 offsprings)Officer 2006-09-25 ~ 2020-11-02OF - Director → CIF 0 - 13
Davies, Philip Benjamin
Director born in July 1977Individual (7 offsprings)Officer 2011-10-01 ~ 2020-11-02OF - Director → CIF 0 - 14PRINCIPLE HEALTHCARE INTERNATIONAL LIMITED - nowBIOCALTH INTERNATIONAL (UK) LIMITED - 2009-07-23Unit 3, Airedale Business Centre, Millenium Road, Skipton, EnglandActive Corporate (1 parent, 1 offspring)Equity (Company account)1,287,351 GBP2024-12-31Person with significant control2016-04-06 ~ 2020-07-01PE - Ownership of shares – 75% or more → CIF 0PE - Ownership of voting rights - 75% or more → CIF 0
Company in focus
PRINCIPLE HEALTHCARE LIMITED
Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
162024-01-01 ~ 2024-12-31
152023-01-01 ~ 2023-12-31
Turnover/Revenue
21,961,936 GBP2024-01-01 ~ 2024-12-31
19,160,585 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
-18,361,803 GBP2024-01-01 ~ 2024-12-31
-16,938,413 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
3,600,133 GBP2024-01-01 ~ 2024-12-31
2,222,172 GBP2023-01-01 ~ 2023-12-31
Distribution Costs
-672,356 GBP2024-01-01 ~ 2024-12-31
-360,558 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-1,283,214 GBP2024-01-01 ~ 2024-12-31
-1,136,086 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
1,644,563 GBP2024-01-01 ~ 2024-12-31
725,528 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
1,573,771 GBP2024-01-01 ~ 2024-12-31
720,526 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
1,204,432 GBP2024-01-01 ~ 2024-12-31
620,730 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
25,153 GBP2024-12-31
31,476 GBP2023-12-31
Fixed Assets
25,153 GBP2024-12-31
31,476 GBP2023-12-31
Total Inventories
5,383,853 GBP2024-12-31
5,174,317 GBP2023-12-31
Debtors
Current
2,796,037 GBP2024-12-31
3,522,662 GBP2023-12-31
Cash at bank and in hand
1,031,412 GBP2024-12-31
735,315 GBP2023-12-31
Current Assets
9,211,302 GBP2024-12-31
9,432,294 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-4,926,323 GBP2024-12-31
Net Current Assets/Liabilities
4,284,979 GBP2024-12-31
3,074,425 GBP2023-12-31
Total Assets Less Current Liabilities
4,310,132 GBP2024-12-31
3,105,901 GBP2023-12-31
Net Assets/Liabilities
4,309,617 GBP2024-12-31
3,105,185 GBP2023-12-31
Equity
Called up share capital
980 GBP2024-12-31
980 GBP2023-12-31
980 GBP2023-01-01
Retained earnings (accumulated losses)
4,308,637 GBP2024-12-31
3,104,205 GBP2023-12-31
2,483,475 GBP2023-01-01
Equity
4,309,617 GBP2024-12-31
3,105,185 GBP2023-12-31
2,484,455 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
1,204,432 GBP2024-01-01 ~ 2024-12-31
620,730 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
1,204,432 GBP2024-01-01 ~ 2024-12-31
620,730 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
1,204,432 GBP2024-01-01 ~ 2024-12-31
620,730 GBP2023-01-01 ~ 2023-12-31
Audit Fees/Expenses
17,300 GBP2024-01-01 ~ 2024-12-31
16,500 GBP2023-01-01 ~ 2023-12-31
Wages/Salaries
801,108 GBP2024-01-01 ~ 2024-12-31
630,279 GBP2023-01-01 ~ 2023-12-31
Social Security Costs
79,817 GBP2024-01-01 ~ 2024-12-31
63,393 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
900,836 GBP2024-01-01 ~ 2024-12-31
705,498 GBP2023-01-01 ~ 2023-12-31
Director Remuneration
291,872 GBP2024-01-01 ~ 2024-12-31
153,019 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-980 GBP2024-01-01 ~ 2024-12-31
-3,521 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
393,443 GBP2024-01-01 ~ 2024-12-31
169,468 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
55,490 GBP2024-12-31
55,490 GBP2023-12-31
Office equipment
40,237 GBP2024-12-31
32,987 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
95,727 GBP2024-12-31
88,477 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
25,943 GBP2023-12-31
Office equipment
31,058 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
57,001 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
11,099 GBP2024-01-01 ~ 2024-12-31
Office equipment, Owned/Freehold
2,474 GBP2024-01-01 ~ 2024-12-31
Owned/Freehold
13,573 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
37,042 GBP2024-12-31
Office equipment
33,532 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
70,574 GBP2024-12-31
Property, Plant & Equipment
Plant and equipment
18,448 GBP2024-12-31
29,547 GBP2023-12-31
Office equipment
6,705 GBP2024-12-31
1,929 GBP2023-12-31
Finished Goods/Goods for Resale
5,383,853 GBP2024-12-31
5,174,317 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
2,533,577 GBP2024-12-31
3,204,425 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
200,000 GBP2024-12-31
228,094 GBP2023-12-31
Other Debtors
Current
1,296 GBP2023-12-31
Prepayments/Accrued Income
Current
62,460 GBP2024-12-31
88,847 GBP2023-12-31
Trade Creditors/Trade Payables
Current
3,304,702 GBP2024-12-31
5,484,439 GBP2023-12-31
Amounts owed to group undertakings
Current
419,117 GBP2024-12-31
1,552 GBP2023-12-31
Corporation Tax Payable
Current
370,011 GBP2024-12-31
112,011 GBP2023-12-31
Taxation/Social Security Payable
Current
592,098 GBP2024-12-31
654,035 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
240,395 GBP2024-12-31
105,832 GBP2023-12-31
Creditors
Current
4,926,323 GBP2024-12-31
6,357,869 GBP2023-12-31
Net Deferred Tax Liability/Asset
-515 GBP2024-12-31
-716 GBP2023-12-31
-9,639 GBP2023-01-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
201 GBP2024-01-01 ~ 2024-12-31
8,923 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
-941 GBP2024-12-31
-2,086 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
980 shares2024-12-31
980 shares2023-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
27,357 GBP2024-12-31
19,575 GBP2023-12-31
Between one and five year
59,787 GBP2024-12-31
47,095 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
87,144 GBP2024-12-31
66,670 GBP2023-12-31
- Registered number 04283476
PRINCIPLE HEALTHCARE LIMITED
InfoAiredale Business Centre, Millenium Road, Skipton, North Yorkshire BD23 2TZPRIVATE LIMITED COMPANY incorporated on 2001-09-07 (24 years 3 months). The company status is Active.The last date of confirmation statement was made at 2025-06-23CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.